You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Malignancy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)

Completed
  • Advanced Malignancy
  • +5 more
  • AMG 820
  • Philadelphia, Pennsylvania
  • +2 more
Jan 18, 2023

Immunotherapy And Palliative Radiotherapy Combined In Advanced

Active, not recruiting
  • Palliative
  • +3 more
  • Palliative Radiation Therapy
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Oct 1, 2021

Melanoma (Skin), Solid Tumor Trial in Australia, United States (PI-88)

Completed
  • Melanoma (Skin)
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Aurora, Colorado
  • +4 more
Jun 21, 2022

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)

Completed
  • Advanced Malignancy
  • +5 more
  • AMG 337
  • Los Angeles, California
  • +7 more
Nov 3, 2022

Solid Tumor, Peritoneal Metastases, Peritoneal Cancer Trial in Haifa, Jerusalem, Ramat Gan (Allocetra-OTS, nivolumab)

Recruiting
  • Solid Tumor
  • +2 more
  • Haifa, Israel
  • +2 more
Oct 12, 2022

Advanced Cancers Trial in Houston (Regorafenib, Cetuximab, Questionnaire)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 31, 2021

Advanced Cervical Cancer Trial in China (TQB2858 injection)

Recruiting
  • Advanced Cervical Cancer
  • TQB2858 injection
  • Nanning, Guangxi Zhuang Autonomous Region, China
  • +16 more
Dec 9, 2021

PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

Approved for marketing
  • PEComa, Malignant
  • +3 more
  • (no location specified)
Mar 2, 2022

Cancer Trial in Beijing (LVGN7409)

Recruiting
  • Cancer
  • LVGN7409
  • Beijing, Beijing, China
    Center Hospital Chinese Academy of Medical Sciences
Dec 7, 2021

Hematologic Malignancies Trial in Shanghai (GNC-035)

Recruiting
  • Hematologic Malignancies
  • Guiyang, Guizhou, China
  • +3 more
Jan 13, 2023

Cancer Trial in Houston (LVGN7409)

Recruiting
  • Cancer
  • LVGN7409
  • Houston, Texas
    MD Anderson Cancer Center
Apr 4, 2022

Advanced Solid Tumor Malignancy Trial in Ghent (KBA1412, Pembrolizumab)

Recruiting
  • Advanced Solid Tumor Malignancy
  • Ghent, Belgium
    University Hospital Ghent
Aug 11, 2022

Cancer Trial in Beijing, Shanghai (LVGN6051, Pembrolizumab)

Recruiting
  • Cancer
  • Beijing, China
  • +1 more
Nov 24, 2021

Advanced Malignancy Trial in Changchun (durvalumab, tremelimumab + durvalumab)

Completed
  • Advanced Malignancy
  • Changchun, China
  • +1 more
Aug 12, 2021

Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)

Recruiting
  • Cancer
  • +2 more
  • engineered red blood cell WTX212
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People'S Hospital
Jan 21, 2023

Distress Associated With Coronavirus Disease 2019 and Telehealth

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Sep 16, 2022

Cancer Trial in Houston (LVGN6051)

Recruiting
  • Cancer
  • LVGN6051
  • Houston, Texas
    MD Anderson Cancer Center
Nov 18, 2021

Advanced Malignancies, Solid Tumor, Hematological Malignancy Trial in Canton, Gettysburg, West Valley City (Pelabresib)

Recruiting
  • Advanced Malignancies
  • +2 more
  • Canton, Ohio
  • +6 more
Jan 30, 2023

Cancer, End Stage Cancer, Malignancy Trial in Baltimore (Community Health Worker (CHW) based palliative care)

Enrolling by invitation
  • Cancer
  • +3 more
  • Community Health Worker (CHW) based palliative care
  • Baltimore, Maryland
    Johns Hopkins University School of Medicine
Nov 8, 2022

Hematologic Malignancy Trial in Boston (Home Transfusion Program Components)

Not yet recruiting
  • Hematologic Malignancy
  • Home Transfusion Program Components
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 18, 2022

Molecular Services and EMR-Lab Integration Application for

Not yet recruiting
  • Advanced Cancer
  • +2 more
  • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
  • limited genetic testing or no testing
  • Rock Hill, South Carolina
    Carolina Blood and Cancer Care Associates
Oct 18, 2023

PelvEx 4: Advanced Pelvic Malignancy and Role of

Not yet recruiting
  • Multidisciplinary Communication
  • +4 more
  • No specific intervention; cases are retrospective and patients have already been treated.
  • Dublin, Ireland
    St. Vincent's Hospital
Oct 12, 2021

HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],

Not yet recruiting
  • HPV-Related Cervical Carcinoma
  • +2 more
  • VB10.16
  • +2 more
  • (no location specified)
Oct 24, 2023

Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

Recruiting
  • Solid Tumor
  • Hematological Malignancy
  • East Melbourne, Victoria, Australia
  • +4 more
Jan 11, 2023